EnWave - CEO, Brent Charleton.
CEO, Brent Charleton.
Source: Business in Vancouver.
  • EnWave (ENW) has entered the Indian market through a technology and evaluation license option agreement with Lalsai Dehy Food
  • LD Food is a Gujarat-based food manufacturer that specializes in dehydrated vegetable and spice products
  • It will evaluate the commercial use of EnWave’s Radiant Energy Vacuum tech on vegetables, herbs, spices and dairy based products
  • If the evaluation proves successful, LD intends to purchase REV machinery to begin production at scale
  • EnWave Corporation is a Vancouver-based technology company that commercializes its REV technology for the precise dehydration of organic materials
  • EnWave (ENW) is unchanged trading at $1.06 per share

EnWave (ENW) has entered the Indian market through a technology and evaluation license option agreement with Lalsai Dehy Food.

LD Food is a Gujarat-based food manufacturer that specializes in dehydrated vegetable and spice products for domestic and export markets. 

It will evaluate the potential commercial use of EnWave’s Radiant Energy Vacuum dehydration technology on a variety of vegetables, herbs, spices and dairy-based products.

To this end, it will rent a 10 kW REV machine for intensive product development at its processing facility in Mahuva, Gujarat. If commercially viable ingredient and snack products are developed, it will look to purchase REV machinery to commence commercial-scale production.

REV technology is currently licensed to over 45 companies in 21 countries worldwide.

EnWave Corporation is a Vancouver-based technology company that commercializes its REV technology for the precise dehydration of organic materials.

EnWave (ENW) is unchanged trading at $1.06 per share as of 12:50 pm ET.

More From The Market Online

Liberty Defense expands its international customer base

Liberty Defense Holdings (TSXV:SCAN), a provider of artificial intelligence technologies, expands its international customer base.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.